Global Recombinant Factor VIII Market Growth 2020-2025
According to this study, over the next five years the Recombinant Factor VIII market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Recombinant Factor VIII business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Factor VIII market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Recombinant Factor VIII, covering the supply chain analysis, impact assessment to the Recombinant Factor VIII market size growth rate in several scenarios, and the measures to be undertaken by Recombinant Factor VIII companies in response to the COVID-19 epidemic.
Segmentation by : breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
200IU
250IU
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Takeda
Bayer
Pfizer
Biogen
CSL
Octapharma
NovoNordisk
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Recombinant Factor VIII consumption (value & volume) by key regions/countries, and , history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Recombinant Factor VIII market by identifying its various subsegments.
Focuses on the key global Recombinant Factor VIII manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Recombinant Factor VIII with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Recombinant Factor VIII submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Factor VIII Consumption 2015-2025
2.1.2 Recombinant Factor VIII Consumption CAGR by Region
2.2 Recombinant Factor VIII Segment 2
2.2.1 200IU
2.2.2 250IU
2.3 Recombinant Factor VIII Consumption 2
2.3.1 Global Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
2.3.2 Global Recombinant Factor VIII Revenue and Market Share 2 (2015-2020)
2.3.3 Global Recombinant Factor VIII Sale Price 2 (2015-2020)
2.4 Recombinant Factor VIII Segment 2
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Recombinant Factor VIII Consumption 2
2.5.1 Global Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
2.5.2 Global Recombinant Factor VIII Value and Market Share 2 (2015-2020)
2.5.3 Global Recombinant Factor VIII Sale Price 2 (2015-2020)
3 Global Recombinant Factor VIII by Company
3.1 Global Recombinant Factor VIII Sales Market Share by Company
3.1.1 Global Recombinant Factor VIII Sales by Company (2018-2020)
3.1.2 Global Recombinant Factor VIII Sales Market Share by Company (2018-2020)
3.2 Global Recombinant Factor VIII Revenue Market Share by Company
3.2.1 Global Recombinant Factor VIII Revenue by Company (2018-2020)
3.2.2 Global Recombinant Factor VIII Revenue Market Share by Company (2018-2020)
3.3 Global Recombinant Factor VIII Sale Price by Company
3.4 Global Recombinant Factor VIII Manufacturing Base Distribution, Sales Area, by Company
3.4.1 Global Recombinant Factor VIII Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Recombinant Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Recombinant Factor VIII by Regions
4.1 Recombinant Factor VIII by Regions
4.2 Americas Recombinant Factor VIII Consumption Growth
4.3 APAC Recombinant Factor VIII Consumption Growth
4.4 Europe Recombinant Factor VIII Consumption Growth
4.5 Middle East & Africa Recombinant Factor VIII Consumption Growth
5 Americas
5.1 Americas Recombinant Factor VIII Consumption by Countries
5.1.1 Americas Recombinant Factor VIII Consumption by Countries (2015-2020)
5.1.2 Americas Recombinant Factor VIII Value by Countries (2015-2020)
5.2 Americas Recombinant Factor VIII Consumption 2
5.3 Americas Recombinant Factor VIII Consumption 2
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Recombinant Factor VIII Consumption by Regions
6.1.1 APAC Recombinant Factor VIII Consumption by Regions (2015-2020)
6.1.2 APAC Recombinant Factor VIII Value by Regions (2015-2020)
6.2 APAC Recombinant Factor VIII Consumption 2
6.3 APAC Recombinant Factor VIII Consumption 2
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Recombinant Factor VIII by Countries
7.1.1 Europe Recombinant Factor VIII Consumption by Countries (2015-2020)
7.1.2 Europe Recombinant Factor VIII Value by Countries (2015-2020)
7.2 Europe Recombinant Factor VIII Consumption 2
7.3 Europe Recombinant Factor VIII Consumption 2
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Factor VIII by Countries
8.1.1 Middle East & Africa Recombinant Factor VIII Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Recombinant Factor VIII Value by Countries (2015-2020)
8.2 Middle East & Africa Recombinant Factor VIII Consumption 2
8.3 Middle East & Africa Recombinant Factor VIII Consumption 2
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Recombinant Factor VIII Distributors
10.3 Recombinant Factor VIII Customer
11 Global Recombinant Factor VIII Market Forecast
11.1 Global Recombinant Factor VIII Consumption Forecast (2021-2025)
11.2 Global Recombinant Factor VIII Forecast by Regions
11.2.1 Global Recombinant Factor VIII Forecast by Regions (2021-2025)
11.2.2 Global Recombinant Factor VIII Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Recombinant Factor VIII Forecast 2
11.8 Global Recombinant Factor VIII Forecast 2
12 Key Players Analysis
12.1 Takeda
12.1.1 Company Information
12.1.2 Recombinant Factor VIII Product Offered
12.1.3 Takeda Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Takeda Latest Developments
12.2 Bayer
12.2.1 Company Information
12.2.2 Recombinant Factor VIII Product Offered
12.2.3 Bayer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Bayer Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Recombinant Factor VIII Product Offered
12.3.3 Pfizer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Biogen
12.4.1 Company Information
12.4.2 Recombinant Factor VIII Product Offered
12.4.3 Biogen Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Biogen Latest Developments
12.5 CSL
12.5.1 Company Information
12.5.2 Recombinant Factor VIII Product Offered
12.5.3 CSL Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CSL Latest Developments
12.6 Octapharma
12.6.1 Company Information
12.6.2 Recombinant Factor VIII Product Offered
12.6.3 Octapharma Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Octapharma Latest Developments
12.7 NovoNordisk
12.7.1 Company Information
12.7.2 Recombinant Factor VIII Product Offered
12.7.3 NovoNordisk Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 NovoNordisk Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Recombinant Factor VIII Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 200IU
Table 5. Major Players of 250IU
Table 6. Global Consumption Sales 2 (2015-2020)
Table 7. Global Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 8. Global Recombinant Factor VIII Revenue 2 (2015-2020) ($ million)
Table 9. Global Recombinant Factor VIII Value Market Share 2 (2015-2020) ($ Millions)
Table 10. Global Recombinant Factor VIII Sale Price 2 (2015-2020)
Table 11. Global Consumption Sales 2 (2015-2020)
Table 12. Global Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 13. Global Recombinant Factor VIII Value 2 (2015-2020)
Table 14. Global Recombinant Factor VIII Value Market Share 2 (2015-2020)
Table 15. Global Recombinant Factor VIII Sale Price 2 (2015-2020)
Table 16. Global Recombinant Factor VIII Sales by Company (2017-2019) (K Units)
Table 17. Global Recombinant Factor VIII Sales Market Share by Company (2017-2019)
Table 18. Global Recombinant Factor VIII Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Recombinant Factor VIII Revenue Market Share by Company (2017-2019)
Table 20. Global Recombinant Factor VIII Sale Price by Company (2017-2019)
Table 21. Global Recombinant Factor VIII Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Recombinant Factor VIII Products Offered
Table 23. Recombinant Factor VIII Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Recombinant Factor VIII Consumption by Regions 2015-2020 (K Units)
Table 25. Global Recombinant Factor VIII Consumption Market Share by Regions 2015-2020
Table 26. Global Recombinant Factor VIII Value by Regions 2015-2020 ($ Millions)
Table 27. Global Recombinant Factor VIII Value Market Share by Regions 2015-2020
Table 28. Americas Recombinant Factor VIII Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Recombinant Factor VIII Consumption Market Share by Countries (2015-2020)
Table 30. Americas Recombinant Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Recombinant Factor VIII Value Market Share by Countries (2015-2020)
Table 32. Americas Recombinant Factor VIII Consumption by Type (2015-2020) (K Units)
Table 33. Americas Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 34. Americas Recombinant Factor VIII Consumption 2 (2015-2020) (K Units)
Table 35. Americas Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 36. APAC Recombinant Factor VIII Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Recombinant Factor VIII Consumption Market Share by Regions (2015-2020)
Table 38. APAC Recombinant Factor VIII Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Recombinant Factor VIII Value Market Share by Regions (2015-2020)
Table 40. APAC Recombinant Factor VIII Consumption 2 (2015-2020) (K Units)
Table 41. APAC Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 42. APAC Recombinant Factor VIII Consumption 2 (2015-2020) (K Units)
Table 43. APAC Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 44. Europe Recombinant Factor VIII Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Recombinant Factor VIII Consumption Market Share by Countries (2015-2020)
Table 46. Europe Recombinant Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Recombinant Factor VIII Value Market Share by Countries (2015-2020)
Table 48. Europe Recombinant Factor VIII Consumption by Type (2015-2020) (K Units)
Table 49. Europe Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 50. Europe Recombinant Factor VIII Consumption 2 (2015-2020) (K Units)
Table 51. Europe Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 52. Middle East & Africa Recombinant Factor VIII Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Recombinant Factor VIII Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Recombinant Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Recombinant Factor VIII Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Recombinant Factor VIII Consumption 2 (2015-2020) (K Units)
Table 57. Middle East & Africa Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 58. Middle East & Africa Recombinant Factor VIII Consumption 2 (2015-2020) (K Units)
Table 59. Middle East & Africa Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Table 60. Recombinant Factor VIII Distributors List
Table 61. Recombinant Factor VIII Customer List
Table 62. Global Recombinant Factor VIII Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Recombinant Factor VIII Consumption Market Forecast by Regions
Table 64. Global Recombinant Factor VIII Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Recombinant Factor VIII Value Market Share Forecast by Regions
Table 66. Global Recombinant Factor VIII Consumption Forecast 2 (2021-2025) (K Units)
Table 67. Global Recombinant Factor VIII Consumption Market Share Forecast 2 (2021-2025)
Table 68. Global Recombinant Factor VIII Value Forecast 2 (2021-2025) ($ Millions)
Table 69. Global Recombinant Factor VIII Value Market Share Forecast 2 (2021-2025)
Table 70. Global Recombinant Factor VIII Consumption Forecast 2 (2021-2025) (K Units)
Table 71. Global Recombinant Factor VIII Consumption Market Share Forecast 2 (2021-2025)
Table 72. Global Recombinant Factor VIII Value Forecast 2 (2021-2025) ($ Millions)
Table 73. Global Recombinant Factor VIII Value Market Share Forecast 2 (2021-2025)
Table 74. Takeda Product Offered
Table 75. Takeda Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Takeda Main Business
Table 77. Takeda Latest Developments
Table 78. Takeda Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Product Offered
Table 80. Bayer Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Bayer Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Product Offered
Table 85. Pfizer Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Pfizer Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 89. Biogen Product Offered
Table 90. Biogen Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Biogen Main Business
Table 92. Biogen Latest Developments
Table 93. Biogen Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 94. CSL Product Offered
Table 95. CSL Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. CSL Main Business
Table 97. CSL Latest Developments
Table 98. CSL Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 99. Octapharma Product Offered
Table 100. Octapharma Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Octapharma Main Business
Table 102. Octapharma Latest Developments
Table 103. Octapharma Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 104. NovoNordisk Product Offered
Table 105. NovoNordisk Basic Information, Company Total Revenue (in $ million), Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 106. NovoNordisk Main Business
Table 107. NovoNordisk Latest Developments
Table 108. NovoNordisk Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Recombinant Factor VIII
Figure 2. Recombinant Factor VIII Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Recombinant Factor VIII Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Recombinant Factor VIII Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 200IU
Figure 7. Product Picture of 250IU
Figure 8. Global Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Figure 9. Global Recombinant Factor VIII Value Market Share 2 (2015-2020)
Figure 10. Recombinant Factor VIII Consumed in Hospital
Figure 11. Global Recombinant Factor VIII Market: Hospital (2015-2020) (K Units)
Figure 12. Global Recombinant Factor VIII Market: Hospital (2015-2020) ($ Millions)
Figure 13. Recombinant Factor VIII Consumed in Pharmacy
Figure 14. Global Recombinant Factor VIII Market: Pharmacy (2015-2020) (K Units)
Figure 15. Global Recombinant Factor VIII Market: Pharmacy (2015-2020) ($ Millions)
Figure 16. Global Recombinant Factor VIII Consumption Market Share 2 (2015-2020)
Figure 17. Global Recombinant Factor VIII Value Market Share 2 (2015-2020)
Figure 18. Global Recombinant Factor VIII Sales Market Share by Company in 2017
Figure 19. Global Recombinant Factor VIII Sales Market Share by Company in 2019
Figure 20. Global Recombinant Factor VIII Revenue Market Share by Company in 2017
Figure 21. Global Recombinant Factor VIII Revenue Market Share by Company in 2019
Figure 22. Global Recombinant Factor VIII Sale Price by Company in 2019
Figure 23. Global Recombinant Factor VIII Consumption Market Share by Regions 2015-2020
Figure 24. Global Recombinant Factor VIII Value Market Share by Regions 2015-2020
Figure 25. Americas Recombinant Factor VIII Consumption 2015-2020 (K Units)
Figure 26. Americas Recombinant Factor VIII Value 2015-2020 ($ Millions)
Figure 27. APAC Recombinant Factor VIII Consumption 2015-2020 (K Units)
Figure 28. APAC Recombinant Factor VIII Value 2015-2020 ($ Millions)
Figure 29. Europe Recombinant Factor VIII Consumption 2015-2020 (K Units)
Figure 30. Europe Recombinant Factor VIII Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Recombinant Factor VIII Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Recombinant Factor VIII Value 2015-2020 ($ Millions)
Figure 33. Americas Recombinant Factor VIII Consumption Market Share by Countries in 2019
Figure 34. Americas Recombinant Factor VIII Value Market Share by Countries in 2019
Figure 35. Americas Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 36. Americas Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 37. United States Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 38. United States Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Recombinant Factor VIII Consumption Market Share by Countries in 2019
Figure 44. APAC Recombinant Factor VIII Value Market Share by Regions in 2019
Figure 45. APAC Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 46. APAC Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 47. China Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 48. China Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 55. India Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 56. India Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Recombinant Factor VIII Consumption Market Share by Countries in 2019
Figure 60. Europe Recombinant Factor VIII Value Market Share by Countries in 2019
Figure 61. Europe Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 62. Europe Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 63. Germany Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 65. France Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 66. France Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 67. UK Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 68. UK Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Recombinant Factor VIII Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Recombinant Factor VIII Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 76. Middle East & Africa Recombinant Factor VIII Consumption Market Share 2 in 2019
Figure 77. Egypt Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Recombinant Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Recombinant Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 87. Global Recombinant Factor VIII Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Recombinant Factor VIII Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 90. Americas Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 91. APAC Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 92. APAC Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 93. Europe Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 94. Europe Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 97. United States Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 98. United States Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 99. Canada Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 100. Canada Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 101. Mexico Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 102. Mexico Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 103. Brazil Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 104. Brazil Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 105. China Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 106. China Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 107. Japan Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 108. Japan Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 109. Korea Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 110. Korea Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 113. India Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 114. India Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 115. Australia Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 116. Australia Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 117. Germany Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 118. Germany Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 119. France Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 120. France Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 121. UK Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 122. UK Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 123. Italy Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 124. Italy Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 125. Russia Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 126. Russia Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 127. Spain Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 128. Spain Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 129. Egypt Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 130. Egypt Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 131. South Africa Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 132. South Africa Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 133. Israel Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 134. Israel Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 135. Turkey Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 136. Turkey Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Recombinant Factor VIII Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Recombinant Factor VIII Value 2021-2025 ($ Millions)
Figure 139. Takeda Recombinant Factor VIII Market Share (2018-2020)
Figure 140. Bayer Recombinant Factor VIII Market Share (2018-2020)
Figure 141. Pfizer Recombinant Factor VIII Market Share (2018-2020)
Figure 142. Biogen Recombinant Factor VIII Market Share (2018-2020)
Figure 143. CSL Recombinant Factor VIII Market Share (2018-2020)
Figure 144. Octapharma Recombinant Factor VIII Market Share (2018-2020)
Figure 145. NovoNordisk Recombinant Factor VIII Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets